`
`IN THE UNITED STATES DISTRICT COURT
`EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`SEAGEN INC.,
`
`v.
`
`Civil Action No. 2:20-CV-00337-JRG
`
`Plaintiff,
`
`
`
`DAIICHI SANKYO CO., LTD.,
`
`Defendant,
`
`ASTRAZENECA PHARMACEUTICALS LP, and
`ASTRAZENECA UK LTD,
`
`
`Intervenor-Defendants.
`
`PLAINTIFF’S OPPOSED MOTION FOR ENTRY OF POST-TRIAL BRIEFING
`SCHEDULE
`
`
`sf-4795081
`
`
`
`Case 2:20-cv-00337-JRG Document 386 Filed 04/22/22 Page 2 of 6 PageID #: 15070
`
`
`Seagen moves for the Court to set a schedule for ruling on Defendants’ prosecution
`
`laches defense and for briefing on any post-trial motions, including Rule 50 or Rule 59 motions,
`
`prior to the entry of a final judgment. Seagen seeks this single, comprehensive briefing schedule
`
`to facilitate an expedient resolution of all post-trial issues with the issuance of a single,
`
`appealable final judgment.
`
`Seagen’s comprehensive post-trial schedule in consistent with the approach used by the
`
`Court in a number of past cases. See, e.g., Smartflash LLC v. Apple, Inc., No. 6:13-CV-447-
`
`JRG, ECF No. 545 (E.D. Tex. April 10, 2015) (briefing all post-trial motions pre-judgment).
`
`Other judges in this district employ similar approaches, including in cases with equitable issues
`
`for decision by the court. See Elbit Sys. Land & C4I Ltd. v. Hughes Network Sys., LLC, No.
`
`2:15-CV-37-RWS-RSP, ECF No. 503 (E.D. Tex. Aug. 24, 2017) (briefing post-trial and
`
`equitable issues simultaneously for resolution pre-judgment); Mars, Inc. v. TruRX, LLC, No.
`
`6:13-CV-526-RWS-KNM, ECF Nos. 389, 392 (E.D. Tex. May 12, 2016, May 24, 2016) (post-
`
`trial schedule briefing all issues pre-judgment); ReedHycalog UK, Ltd. v. Diamond Innovations
`
`Inc., No. 6:08-CV-325-LED, ECF No. 289 (E.D. Tex. June 10, 2010) (same).
`
`Here, Defendants’ affirmative defense of prosecution laches was bifurcated. (Dkt. 347 at
`
`2.) On April 12, 2022, Seagen proposed a schedule to Defendants to take the prosecution laches
`
`issue up by submission to the Court, with briefing completed by May 27, 2022. Defendants did
`
`not agree to the proposed schedule. (Ex. A at 1–2.) On April 20, 2022, Seagen followed up,
`
`proposing one briefing schedule for all pending post-verdict issues. (Id. at 1.) In a meet and
`
`confer on April 22, 2022, Defendants did not agree to the proposed schedule, and instead
`
`suggested they would be seeking a stay.
`
`Defendants’ rationale for a stay is to push out entry of a final, appealable judgment in this
`
`case in favor of proceedings before the Patent Office. As Defendants noted during trial, the
`
`
`sf-4795081
`
`1
`
`
`
`Case 2:20-cv-00337-JRG Document 386 Filed 04/22/22 Page 3 of 6 PageID #: 15071
`
`
`Patent Trial and Appeal Board instituted Post Grant Review of the asserted claims of the ’039
`
`patent on April 7, 2022. (April 8, 2022 Tr. at 49:25-50:5.) The PTAB has scheduled a hearing
`
`for January 17, 2023 and a Final Written Decision by the PTAB is expected around April 7,
`
`2023.1 A delay in resolving the post-verdict proceedings in this case will increase the likelihood
`
`that any appeal of the jury verdict from this litigation will be pending when the Final Written
`
`Decision issues and the non-prevailing party appeals that decision, which could result in
`
`conflicting appeals before the Federal Circuit.
`
`Seagen proposes the following schedule for disposition of Defendants’ prosecution laches
`
`defense and for briefing on any post-trial motions, including Rule 50 or Rule 59 motions:
`
`Date
`May 6, 2022
`
`May 27, 2022
`June 3, 2022
`June 10, 2022
`
`Event
`Deadline to file all post-trial motions and any
`opening brief regarding prosecution laches
`Deadline to file oppositions
`Deadline to file replies to oppositions
`Deadline to file sur-replies
`
`Page Limits
`50
`
`50
`15
`15
`
`
`
`In its opening motions, Seagen intends to seek enhanced damages under 35 U.S.C. § 284,
`
`an on-going and enhanced royalty rate and supplemental damages, and an exceptional case
`
`finding and attorney fees under 35 U.S.C. § 285. Should the Court find the case exceptional and
`
`award Seagen attorney fees in the final judgment, Seagen proposes submissions regarding the
`
`amount of attorney fees occur post-judgment without extending the time to appeal, consistent
`
`with Fed. R. Civ. P. 54(d), 58(e), and Fed. R. App. P. 4(a)(4)(A)(iii).
`
`Seagen’s proposal does not include a bench trial on prosecution laches because Seagen
`
`believes testimony on this issue from the parties’ experts is unlikely to aid the Court in resolving
`
`
`1 On April 21, 2022, Seagen sought rehearing of the PTAB’s institution decision, noting the
`verdict in this litigation. Defendants’ invalidity defenses in the PTAB proceedings are identical
`to those the jury decided in this case.
`
`
`sf-4795081
`
`2
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 386 Filed 04/22/22 Page 4 of 6 PageID #: 15072
`
`
`the defense and could be submitted by declarations with the briefing if truly necessary and non-
`
`cumulative of the experts’ reports and deposition testimony. The facts relating to the defense
`
`were all adduced in the jury trial, and the only opinion Defendants’ expert provides over the
`
`current record is his view of the law.2 (Ex. B.) Nonetheless, should the Court determine a bench
`
`trial would be helpful for resolving prosecution laches, a single day should be set in May 2022,
`
`with proposed findings of fact and conclusions of law due no later than June 10, 2022. This
`
`would allow the Court to consider all remaining open issues in tandem and issue judgment
`
`promptly.
`
`In the interest of expedient resolution of all remaining issues to facilitate entry of a final,
`
`appealable judgment, Seagen requests entry of this comprehensive post-trial briefing schedule.
`
`
`2 A bench trial is also unnecessary because Defendants’ prosecution laches defense lacks any
`serious merit. The asserted patent is post-GATT, and it is black letter law that it is permissible to
`draft claims directed to a competitor’s product. See, e.g., Chrimar Sys., Inc. v. Alcatel-Lucent
`Enter. USA Inc., No. 6:15-CV-00163-JDL, 2017 WL 345991, at *4 (E.D. Tex. Jan. 24, 2017)
`(explaining that GATT-based provisions “alleviate the need for the equitable remedy … based
`on a delayed prosecution”); BlephEx, LLC v. Myco Indus., Inc., 24 F.4th 1391, 1404 (Fed. Cir.
`2022) (“[T]here is nothing improper, illegal, or inequitable in filing a patent application for the
`purpose of obtaining a right to exclude a known competitor’s product from the market.”)
`(quoting Kingsdown Med. Consultants, Ltd. v. Hollister Inc., 863 F.2d 867, 874 (Fed. Cir.
`1988)). Thus, prosecution laches does not apply as a matter of law.
`
`3
`
`sf-4795081
`
`
`
`
`
`Case 2:20-cv-00337-JRG Document 386 Filed 04/22/22 Page 5 of 6 PageID #: 15073
`
`
`Dated: April 22, 2022
`
`
`sf-4795081
`
`
`
`By: /s/ Michael A. Jacobs
`Michael A. Jacobs
`MJacobs@mofo.com
`Matthew A. Chivvis
`MChivvis@mofo.com
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, CA 94105
`Telephone: 415.268.7000
`Facsimile: 415.268.7522
`
`Bryan Wilson
`BWilson@mofo.com
`MORRISON & FOERSTER LLP
`755 Page Mill Road
`Palo Alto, California 94304-1018
`Telephone: 650.813.5600
`Facsimile: 650.494.0792
`
`Melissa R. Smith
`Texas State Bar No. 24001351
`melissa@gillamsmithlaw.com
`GILLAM & SMITH, LLP
`303 South Washington Avenue
`Marshall, Texas 75670
`Telephone: 903.934.8450
`Facsimile: 903.934.9257
`Of Counsel:
`T. John Ward, Jr.
`Texas State Bar No. 00794818
`jw@wsfirm.com
`Wesley Hill
`Texas Bar No. 24032294
`wh@wsfirm.com
`Charles Everingham IV
`Texas State Bar No. 00787447
`ce@wsfirm.com
`Andrea L. Fair
`Texas State Bar No. 24078488
`andrea@wsfirm.com
`WARD, SMITH & HILL, PLLC
`1507 Bill Owens Parkway
`Longview, Texas 75604
`Telephone: 903.757.6400
`Facsimile: 903.757.2323
`
` Attorneys for Plaintiff Seagen Inc.
`4
`
`
`
`Case 2:20-cv-00337-JRG Document 386 Filed 04/22/22 Page 6 of 6 PageID #: 15074
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that counsel of record who are deemed to have
`
`consented to electronic services are being served with a copy of this document via the Court’s
`
`CM/ECF system per Local Rule CV-5(a)(3) on this the 22nd day of April, 2022.
`
`
`
`
`
` /s/ Melissa R. Smith
`
`
`
`CERTIFICATE OF CONFERENCE
`
`On April 12, 2022, Seagen proposed a schedule to Defendants to take the prosecution
`
`laches issue up by submission to the Court, with briefing completed by May 27, 2022.
`
`Defendants said they would evaluate the proposal, but suggested they were unlikely to agree. On
`
`April 20, 2022, Seagen followed up, proposing one briefing schedule for all pending post-verdict
`
`issues. Defendants again suggested they were unlikely to agree. The parties held a meet and
`
`confer on April 22, 2022. In that discussion, Defendants did not agree to the proposed schedule,
`
`and instead suggested they would be seeking a stay of this litigation in light of the April 7, 2022,
`
`institution decision by the PTAB. Seagen noted it would thus be filing this motion opposed, and
`
`requested that Defendants agree to expedited briefing on a schedule. Defendants requested that
`
`they be permitted to evaluate this motion before stating a position on expedited briefing, but
`
`again noted they intend to seek a stay. Seagen responded that it would file an opposed motion
`
`for expedited briefing if Defendants do not agree, and intends to file that motion on Monday if
`
`the parties have not agreed to a briefing schedule by then.
`
`
`
`
`
`sf-4795081
`
` /s/ Melissa R. Smith
`
`5
`
`
`
`
`
`